Supplementary Figure S7 from PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy

Authors

Toyoyuki Hanazawa (ORCID: https://orcid.org/0000-0001-9721-5662)
Katsushige Kawase (ORCID: https://orcid.org/0000-0001-6998-8481)
Takao Morinaga (ORCID: https://orcid.org/0000-0002-0305-7008)
Masahito Kawazu
Yosuke Togashi (ORCID: https://orcid.org/0000-0001-9910-0164)
Takashi Inozume (ORCID: https://orcid.org/0000-0001-7054-1863)
Shusuke Kawashima (ORCID: https://orcid.org/0000-0001-6628-4331)
Tatsuya Nishi (ORCID: https://orcid.org/0009-0003-9568-7262)

Publication Details

Published: 2025-10-01
DOI: https://doi.org/10.1158/2326-6066.30255043
Primary Topic: Immune Cell Function and Interaction
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Supplementary Figure S7 from PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy

Toyoyuki Hanazawa, Katsushige Kawase, Takao Morinaga, Masahito Kawazu et al.

Oct 1, 2025

Immune Cell Function and Interaction

article

Supplementary Figure S7 from PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy

Toyoyuki Hanazawa, Katsushige Kawase, Takao Morinaga, Masahito Kawazu, Yosuke Togashi, Takashi Inozume, Shusuke Kawashima, Tatsuya Nishi

October 1, 2025article en

Abstract

No abstract available for this paper.

Openalex Percentile: Top 71%

Immune Cell Function and Interaction

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Supplementary Figure S7 from PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy — Toyoyuki Hanazawa, Katsushige Kawase, et al. · (2025) | TGRS Research Map | TGRS